Further in vitro studies demonstrated that mutant IDH1/2 alters the TCA metabolic fluxes leading to increased dependence on glutaminolysis [61–63] and compromised multiple DNA repair pathways, ultimately making tumor cells more susceptible to radiation and chemotherapy [64–67]. The gene discussed is IDH1; the disease is neoplasm.